LONG-TERM FOLLOW-UP OF PATIENTS WITH CHOROIDEREMIA WITH SCLERAL PITS AND TUNNELS AS A NOVEL OBSERVATION
- PMID: 28937528
- DOI: 10.1097/IAE.0000000000001844
LONG-TERM FOLLOW-UP OF PATIENTS WITH CHOROIDEREMIA WITH SCLERAL PITS AND TUNNELS AS A NOVEL OBSERVATION
Abstract
Purpose: To evaluate the long-term clinical course and visual outcome of patients with choroideremia.
Methods: Clinical examination, a social questionnaire, and medical records review of 21 patients with choroideremia from 14 families.
Results: The mean follow-up time was 25.2 years (SD: 13.3; range 2-57 years). The mean age at symptom onset was 15.1 years (SD: 10.1; range 5-40 years). Best-corrected visual acuity was stable until the age of 35 (P = 0.96), but declined significantly faster after the age of 35 (11%/year, P = 0.001), with a high variability between individual patients. The mean age at which patients discontinued working was 48.1 years (SD: 11.7, range 25-65 years). The reason for work discontinuation was vision related in 60% of cases. Most patients (70%) reported visual field constriction as the most debilitating symptom. The authors report scleral pits and tunnels as a novel finding visible on spectral domain optical coherence tomography and ophthalmoscopy.
Conclusion: Choroideremia is a severely debilitating disease showing a rapid decline of visual acuity generally after the age of 35, but a more gradual decline for other abnormalities.
Similar articles
-
SCLERAL PITS IN CHOROIDEREMIA: Implications for Retinal Gene Therapy.Retina. 2018 Sep;38(9):1725-1730. doi: 10.1097/IAE.0000000000001957. Retina. 2018. PMID: 29160785 Free PMC article.
-
Clinical and Genetic Features of Choroideremia in Childhood.Ophthalmology. 2016 Oct;123(10):2158-65. doi: 10.1016/j.ophtha.2016.06.051. Epub 2016 Aug 6. Ophthalmology. 2016. PMID: 27506488
-
Visual Function and Central Retinal Structure in Choroideremia.Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT377-87. doi: 10.1167/iovs.15-18421. Invest Ophthalmol Vis Sci. 2016. PMID: 27409497
-
Central Serous Chorioretinopathy.Dev Ophthalmol. 2017;58:27-38. doi: 10.1159/000455267. Epub 2017 Mar 28. Dev Ophthalmol. 2017. PMID: 28351043 Review.
-
CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.Retina. 2019 Nov;39(11):2059-2069. doi: 10.1097/IAE.0000000000002553. Retina. 2019. PMID: 31021898 Free PMC article. Review.
Cited by
-
Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial.Nat Med. 2023 Oct;29(10):2464-2472. doi: 10.1038/s41591-023-02520-3. Epub 2023 Oct 9. Nat Med. 2023. PMID: 37814062 Free PMC article. Clinical Trial.
-
Outer retinal and choriocapillaris modifications in choroideremia: three differentially impaired retinal regions and the potential diagnostic role of the external limiting membrane.Eye (Lond). 2023 Feb;37(2):338-343. doi: 10.1038/s41433-022-01953-3. Epub 2022 Jan 28. Eye (Lond). 2023. PMID: 35091709 Free PMC article.
-
Bilateral visual acuity decline in males with choroideremia: a pooled, cross-sectional meta-analysis.BMC Ophthalmol. 2022 Jan 16;22(1):29. doi: 10.1186/s12886-022-02250-z. BMC Ophthalmol. 2022. PMID: 35034620 Free PMC article.
-
Retinal Dystrophies and the Road to Treatment: Clinical Requirements and Considerations.Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):159-179. doi: 10.1097/APO.0000000000000290. Asia Pac J Ophthalmol (Phila). 2020. PMID: 32511120 Free PMC article. Review.
-
Next-generation sequencing-based clinical diagnosis of choroideremia and comprehensive mutational and clinical analyses.BMC Ophthalmol. 2020 Jun 1;20(1):212. doi: 10.1186/s12886-020-01478-x. BMC Ophthalmol. 2020. PMID: 32487042 Free PMC article.
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
